Endocrine Surgery Guidelines During the COVID-19 Pandemic

Yelda Jozaghi from The University of Texas MD Anderson Cancer Center authored a paper outlining surgical triaging guidelines for endocrine surgery during the COVID-19 pandemic. The work was developed by an institutional multidisciplinary group and aligns with phases of care published by the American College of Surgeons. It provides context for endocrine surgery within surgical oncology, aiming for optimal individualized patient care during a period of significant resource diversion.

Use Cases

• Analyze surgical triaging recommendations based on the described phases of care.
• Study the adaptation of cancer care protocols based on CDC and ACS recommendations mentioned in the description.
• Model resource allocation for endocrine surgery based on the guideline's focus on deferring non-urgent cases.
• Review case prioritization examples for differentiated and medullary thyroid cancers as outlined in the paper.

Strengths

• Authored by a researcher from a major cancer center (The University of Texas MD Anderson Cancer Center).
• Guidelines were developed by a multidisciplinary group including Head and Neck Surgical Oncology, Surgical Endocrinology, and Medical Endocrinology.
• Aligns with formal recommendations from the Centers for Disease Control and Prevention (CDC) and the American College of Surgeons (ACS).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

The University of Texas MD Anderson Cancer Center

Collection Method

An institutional multidisciplinary group devised guidelines aligned with ACS phases of care.

Time Range

Coronavirus Disease 2019 Pandemic period